110 related articles for article (PubMed ID: 3004370)
1. [Interaction between calcium inhibitors and vascular alpha-adrenergic receptors].
van Zwieten PA; Timmermans PB
Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():7-13. PubMed ID: 3004370
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of calcium entry blockers: interaction with vascular alpha-adrenoceptors.
van Zwieten PA; van Meel JC; Timmermans PB
Hypertension; 1983; 5(4 Pt 2):II8-17. PubMed ID: 6134673
[TBL] [Abstract][Full Text] [Related]
3. Vascular aspects of calcium antagonists.
Van Zwieten PA; Van Meel JC; Timmermans PB
Pharm Weekbl Sci; 1981 Dec; 3(6):237-47. PubMed ID: 6120500
[TBL] [Abstract][Full Text] [Related]
4. Calcium antagonists and alpha 2-adrenoceptors: possible role of extracellular calcium ions in alpha 2-adrenoceptor-mediated vasoconstriction.
van Zwieten PA; van Meel JC; Timmermans PB
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S273-9. PubMed ID: 6184552
[TBL] [Abstract][Full Text] [Related]
5. [Interaction between calcium antagonists and vascular postsynaptic alpha-receptors].
van Meel JC; Timmermans PB; van Zwieten PA
J Pharmacol; 1982; 13(3):367-79. PubMed ID: 6290792
[TBL] [Abstract][Full Text] [Related]
6. Specific alpha-adrenoceptor-mediated vasoconstriction in human veins and interaction with the calcium entry blockers nifedipine and diltiazem.
Schulte KL; Laber E; Meyer-Sabellek WA; Distler A; Gotzen R
J Hypertens Suppl; 1985 Dec; 3(3):S239-41. PubMed ID: 2856818
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.
Cavero I; Shepperson N; Lefèvre-Borg F; Langer SZ
Circ Res; 1983 Feb; 52(2 Pt 2):I69-76. PubMed ID: 6131754
[TBL] [Abstract][Full Text] [Related]
8. Binding of [3H]prazosin to porcine aortic membranes: interaction of calcium antagonists with vascular alpha-1 adrenoceptors.
Nishimura J; Kanaide H; Nakamura M
J Pharmacol Exp Ther; 1986 Mar; 236(3):789-93. PubMed ID: 3005556
[TBL] [Abstract][Full Text] [Related]
9. Postsynaptic alpha adrenoceptors on vascular smooth muscle.
Matthews WD; Jim KF; Hieble JP; DeMarinis RM
Fed Proc; 1984 Nov; 43(14):2923-8. PubMed ID: 6092150
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of calcium antagonist drugs on vasoconstriction induced by vascular alpha 2-adrenoceptor stimulation.
van Zwieten PA; Timmermans PB; Thoolen MJ; Wilffert B; De Jonge A
Am J Cardiol; 1986 Feb; 57(7):11D-15D. PubMed ID: 2869674
[TBL] [Abstract][Full Text] [Related]
11. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
Altura BM; Altura BT
Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
[TBL] [Abstract][Full Text] [Related]
12. Alpha 2-adrenergic receptors and calcium: alpha 2-receptor blockade in vascular smooth muscle as an approach to the treatment of hypertension.
Lee JY; DeBernardis JF
Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):213-25. PubMed ID: 1972206
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction between calcium antagonists and the vasoconstriction induced by the stimulation of postsynaptic alpha 2-adrenoceptors.
van Zwieten PA; van Meel JC; Timmermans PB
Circ Res; 1983 Feb; 52(2 Pt 2):I77-80. PubMed ID: 6299607
[No Abstract] [Full Text] [Related]
14. Receptor subtypes involved in the action of calcium entry blockers.
van Zwieten PA; Timmermans PB
Ann N Y Acad Sci; 1988; 522():351-60. PubMed ID: 2454059
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
16. Existence of spare alpha 1-adrenoreceptors, but not alpha 2-adrenoreceptors, for respective vasopressor effects of cirazoline and B-HT 933 in the pithed rat.
Ruffolo RR; Yaden EL
J Cardiovasc Pharmacol; 1984; 6(6):1011-9. PubMed ID: 6084756
[TBL] [Abstract][Full Text] [Related]
17. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
Opie LH
Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vascular myogenic tone and reactivity by calcium antagonists.
Nordlander MI
J Hypertens Suppl; 1989 Sep; 7(4):S141-5; discussion S146. PubMed ID: 2681591
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
[TBL] [Abstract][Full Text] [Related]
20. Calcium and alpha-adrenoceptors in activation of vascular smooth muscle.
Vanhoutte PM; Rimele TJ
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S280-6. PubMed ID: 6184553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
